The pioneering trial used two drugs, tucatinib and trastuzumab, to treat patients with a variety of tumours linked to a protein in the body called human epidermal growth factor receptor 2, or HER2
Source link : https://www.dailymail.co.uk/health/article-14006791/Breast-cancer-drugs-liver-tumours-bile-duct-cancer-Japan.html?ns_mchannel=rss&ito=1490&ns_campaign=1490
Author :
Publish date : 2024-10-27 01:59:21
Copyright for syndicated content belongs to the linked Source.